Researchers identify new melatonin-based molecular targets that will allow to design new drugs against Parkinson's
A team of scientists led by Darío Acuña-Castroviejo, professor at the University of Granada (UGR), has published the results of a new breakthrough in molecular mechanisms of the anti-Parkinsonian activity of melatonin.
Jan 11, 2018
0
6